BioSpace News Archive

FDA

FDA Greenlights Two Novartis Drugs, Including First for Adult-Onset Still’s Disease

Novartis is the first company to the finish line with an approved treatment for Adult-Onset Still’s Disease (AOSD), a rare autoinflammatory disease of unknown origin.

June 17, 2020
·
2 min read
·
Alex Keown
Drug Development

Could ‘Helper’ T Cells Pave the Way for COVID-19 Immunity?

Researchers found that certain individuals who have never been exposed to COVID-19 appear to have “helper” T cells that are capable of recognizing and responding to the virus.

June 17, 2020
·
2 min read
·
Krystle Vermes
Biotech Bay

Orca Bio Raises $192 Million Series D for Cell Therapies

Orca Bio closed on a Series D financing worth $192 million, bringing the total raised since 2016 to $300 million.

June 17, 2020
·
3 min read
·
Mark Terry
Biotech Beach

Lassen Therapeutics Raises $31 Million to Pursue IL-11 Antibody for Cancer and Fibrosis

Lassen Therapeutics, based in San Diego, came out of stealth mode with a $31 million Series A financing round. The round was led by Frazier Healthcare Partners with participation from Alta Partners and Longwood Fund.

June 17, 2020
·
3 min read
·
Mark Terry
FDA

FDA Approves Second Biomarker-Specific Indication for Merck’s Keytruda

This is the second such biomarker-specific approval for Keytruda. The first biomarker-specific approval came in 2017.

June 17, 2020
·
2 min read
·
Alex Keown
Business

The Implications of Workplace COVID-19 Testing for Biotech, Pharma and Others

Numerous biopharma companies are testing or working to develop drugs and vaccines. But what is a bit unusual is the number of staffers at biotech and pharma companies and health care involved as participants in studies and clinical trials.

June 17, 2020
·
5 min read
·
Mark Terry
Business

COVID-19 Stresses Manufacturing Capacities and Funders’ Understanding

The race toward a COVID-19 vaccine is focused around scientific development right now, but companies also need to be planning for manufacturing.

June 17, 2020
·
4 min read
·
Gail Dutton
Drug Development

BioMarin Shares Additional Promising Phase I/II Data on Hemophilia A Treatment

BioMarin Pharmaceutical released new data today from its previously reported four-year update of the open-label Phase I/II study of valoctocogene roxaparvovec.

June 17, 2020
·
3 min read
·
Krystle Vermes
BioSpace Global Roundup, June 18

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.

June 17, 2020
·
7 min read
·
Alex Keown
Pharm Country

Phosphorus Announces Partnership With BioIQ to Make Phosphorus’ At-Home COVID-19 Saliva Test More Accessible To People Across The Country

Partnership Allows Easy Access of the Tests to Clinical Care and Employer Health Programs

June 17, 2020
·
4 min read